13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 27 holding rows worth $820,776,000.
- Accession
- 0001085146-20-002982
- Filer
- CIK 1544773
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 27 entries on the cover page, a total value of $820,776,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $820,776,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MACROGENICS INC | 556099109 | COM | 3,747,298 | $94,394,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 5,299,863 | $75,258,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 3,468,171 | $64,577,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 4,685,527 | $60,724,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 14,007,548 | $54,910,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 7,994,904 | $47,969,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,369,709 | $46,328,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 2,637,421 | $42,858,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 2,374,392 | $36,376,000 | thousands by filing date | |
| APREA THERAPEUTICS INC | 03836J102 | COM | 1,459,411 | $35,113,000 | thousands by filing date | |
| LIMINAL BIOSCIENCES INC | 53272L103 | COM | 3,084,627 | $34,325,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,969,875 | $32,385,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 1,509,819 | $30,680,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,005,218 | $29,717,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 602,732 | $28,732,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 3,844,994 | $21,686,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 1,736,012 | $18,957,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W203 | COM | 3,236,335 | $14,952,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 3,135,176 | $11,224,000 | thousands by filing date | |
| CASI PHARMACEUTICALS INC | 14757U109 | COM | 6,560,000 | $10,037,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 793,170 | $7,686,000 | thousands by filing date | |
| SOLENO THERAPEUTIVS, INC. | 834203200 | COMM | 3,040,000 | $7,630,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 484,042 | $4,891,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,558,290 | $3,724,000 | thousands by filing date | |
| DEERFIELD HEALTHCARE TECH AC | 244413209 | UNIT 07/16/2025 | 250,000 | $2,658,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 180,000 | $1,865,000 | thousands by filing date | |
| FS DEV CORP | 303020101 | COM CL A | 100,000 | $1,120,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-20-002982 | this filing | 2020-11-16 | acceptance time not in the bulk data set |